pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3607 |
Genomic Coordinates | chr5: 86620497 - 86620575 |
Description | Homo sapiens miR-3607 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-3607-3p |
Sequence | 51| ACUGUAAACGCUUUCUGAUG |70 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FOXK2 | ||||||||||||||||||||
Synonyms | ILF, ILF-1, ILF1 | ||||||||||||||||||||
Description | forkhead box K2 | ||||||||||||||||||||
Transcript | NM_004514 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FOXK2 | |||||||||||||||||||||
3'UTR of FOXK2 (miRNA target sites are highlighted) |
>FOXK2|NM_004514|3'UTR 1 CGACCGGGAGAGCTTTTCTTTAACGATATCAACTCTGTGGTGCCAAAAGGAGACGCGGCCTCCCGCCAGCACTCGGGGGT 81 GCAGGGCCCTGTGGTTGGACTTCACCTCTCAGCACTGAAAACCCAAAACCCAGCTGGCCTTAACACTCCTTAAAGACAGA 161 AGTCACACTTGAACAAAACCCACACACAACAAAACCTGATTTGGGAGACGGTGTCTCCACTGAGCACCTGCTGGGCTGAG 241 CTTCTACCTACGAGTGAAACTCTGTCCTCCCGCGAGGACCAGGCATCGCTGTGTGAGGACGGCACGGCCAGCGCCTGCTG 321 TGAGTGGGTCTCCCAAGACTAGGCCTCAGGACGCGGGGGGAGCCATCCCCGCCGCCCTCACAGGACCCACCAGGCAGCGG 401 AGACATGTGGAATTAGAGTATTTTGAGGTGTCCTTTCTTTACAAAATAATGGGGTCTTGGGCATTTCACATCACTCCATT 481 TCTACTGAGACTTTCAGAATCACACAGGCCCTTTCCGTGGATTTCATTTGGGGCAAAGAAACAACGTAGTTTTGTTTTTG 561 TTTTCAGCCTATGGAATGATTTCCTTTTGTCTGTCTTGTTCAAGTTCAGACGAAGCTACTCTGGCATCTGCACATTTCCG 641 TGTTACAGCAGCTGCCTGATGAATTTTATCCACCTCCATTTCAGCATGTGGCTCGCGTGGACAGGTGGACGGACGCTGTG 721 GCCGCATGGAACCTTGAGAACCCAGGGACGAGCCAGTGCCGGGAAGGAACTGCCGGGACTCACCGAGCTGCACTTAACTG 801 TTCTCTTTCTGGCTATTTTTTGTTGTTTGTTTCTTTGTGTTGACTTTGTCCCTGGCAAAATTTTCCACTCTGAGTAAAAC 881 AAGTCTCCTAAGTATTGTGTATGTTTAAAACGACAGAACCATTTCTACTTCATTTGGAAAAAGATTCAGTCTTTTATCAC 961 AGGCCCTTTTGAAACTCAGATCCCAGGTCTCTCCGTGGTATGTTTGTATTTGGGGTGTCCCTCCGGCTCTAGGCGGCCTC 1041 TGACCTGCTGTCTACTCCCCACCTTCGGTGAGCGGCCGCCATGGTGGAGCAGGGTCCGAGCCACGTCCTGCAGGGCACGT 1121 CTGGGGCATTTCCTGTTTTGTGGTAGGAAATGTCCCTGACCTTTCAGAACCGAACCCAATCCTGAGGCTGACTCCTCTAC 1201 GGAAAATGAGGACAGGACGGGGGTGAGGGAATGAGAGTGGGAGGTCCCTGCACCTCCTCGCCCGGCTCCTCAGGAAGAAA 1281 ACCGCTGGCCCTTCCCGAGTGTGCCGGCCGAGGGCCGAGGGCCGTGCACATGGGGAGAGGGCGTCAGCCTGATGGCTGAG 1361 CTTTTAAATGTCATCATCATAACATTATTTATTTAAATGTAGTTATTTTGGTATTTAATTTTTTTTTAGAGAGGAAAAAA 1441 CCTGTATTTTCCTGGTGGGATGAAATAGGGATGAAATGGCTCAGAATGGTATATTTAGGCAATTTTAAAACATTTATTAT 1521 TTACATAAAGACCAAATATGATGAATCTGTTCCGTGAATTGTGTCGGCCCTCAGCATGGGGCTGGGGCAGCGTCACTGCG 1601 GTGACGCCCATTGAAAGGTATGAAATGACTGCACACTAGCTGGATTATCACTCAGCCGTTTAAGAAATAAAAGCAAAACC 1681 ATCACGTGACTGAGACCGTGTGTGTGACCGCAGCAAAGCGCAGCGTGTGGATGGATCAGAGCCCCTCGGTGCAGCTGTCT 1761 GCATCTTCCAAGCACTTTACAGATACCTTGGAATGTATATTTTTGTCTTCTTACTCAGAAGGTTTGCAGTTTGTAAAATA 1841 ATCAGGATTCTGCTCTGTCCTGTGTGTGGGGTCAGCTCCCTCCACAGAGGGCTCCAGCTCTGTTGGTCACAGCTGATGGG 1921 GTTCTCTGATTGATAGGAGACGAGCTCTTGAGCTCTAAGGAACAGTGAGGTCGCCGGTGGGGAGCTTGGCTGGGACACCA 2001 AGCAAATGCATCGTATGTCCCCTTGGAGACGTTTTTATGCAGCTGTGTATGTTACTATCCAGAAGGAGTCGGGGGTAGAC 2081 TTTCCCGTGTAAGCTCAGTCCATAAACTGGTTACTTCTGATCCTGGAACGTGGACTTCACATGATAGGTCTGGATCTGTT 2161 TCTGTTGGGATCACAGGTAAGGAAAATGTCCATTCAAATGGTAAAGAAGGGAGGAGGGTGTTTTTTTTTTTTTTTTTTGC 2241 CGTAGGCACCATTCTGCATCTTGAACCCAGACTGAAGTGTGCCTCTCACAGATGGAAGGTGCACACGCTCCTGTCTCCTC 2321 CTCACTCTGCCACGTTCACTTGGCTTTTTCATTGGTACCTAGGAATTTAAGAATATCGAAGCGAGAGCAGTAACAAACCA 2401 TAGATGAGCAGACTCCCACACCGGGTTTTCTTGCCCGTCTTTAAGGCACTGTTTCTAAATTTTGAACTTAGCTCTGAATC 2481 CCCAAGAACTTGAGCACAGCAAGGGTTGCTGAGCTGCTGTCGCCGCAGCCCTGGCCCCTGGTGCTGGAGCTGCAGCACCT 2561 TTGGGAGAGGTCCTGCGTCGTCCTCAGCTGCGTCGCTGTGAACTCCCGCTCTCCACTGTGTTCCTCAGTGTCTGCTTTTC 2641 AGGAAGTCTGCTGTGACCTTTGCCCAACTTCTGAGCTCCTCAGGGACTAGGAACAATTTCAGTAGCTTTGCCCTGAACCA 2721 AACGAGAAAACAAAAGGGAACTCCCGTATGACCCACGTCACGTGGTGCACTCAGAGTGTGTGCGGCATGATCCTCGGTTG 2801 CTCCTCCTCTCACTTTAGTAGAGTACGCGGTGGACAGCTGATCTCCTTCAGTCGTCTACCCACTTCCGTCATTGTCCTCC 2881 GCTAGAATAACAGAGTAGTTGGTAGTCATGGCCAGAAGGGGGGTGGGGGCAGTGTGAGGACTTGGGGTTTCTGTGCTGTG 2961 TGACACAAGGAGATAAGTGACAATCTTGAAGTCCTAACTTCCACTATTCTAGAAAGTATAGTGGTGATTTGTGTGCAAAG 3041 ATTTGAAGTTTTAAAAAAGTACCAAGTTCCTGAAATTCAATAAAATATTTTTATTAATTTTAATGGAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 3607.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 3607.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000335255.5 | 3UTR | CAUCUUCCAAGCACUUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000335255.5 | 3UTR | CAUCUUCCAAGCACUUUACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
93 hsa-miR-3607-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT057680 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT058092 | EIF4G2 | eukaryotic translation initiation factor 4 gamma 2 | 2 | 4 | ||||||||
MIRT063624 | FBXO28 | F-box protein 28 | 2 | 2 | ||||||||
MIRT071884 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT079440 | FOXK2 | forkhead box K2 | 2 | 4 | ||||||||
MIRT080491 | BCL10 | B-cell CLL/lymphoma 10 | 2 | 2 | ||||||||
MIRT081214 | MIDN | midnolin | 2 | 10 | ||||||||
MIRT082786 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT082862 | ZNF543 | zinc finger protein 543 | 2 | 4 | ||||||||
MIRT099112 | FOXC1 | forkhead box C1 | 2 | 4 | ||||||||
MIRT099343 | QKI | QKI, KH domain containing RNA binding | 2 | 2 | ||||||||
MIRT100913 | CD2AP | CD2 associated protein | 2 | 2 | ||||||||
MIRT104030 | USP42 | ubiquitin specific peptidase 42 | 2 | 6 | ||||||||
MIRT130023 | QSER1 | glutamine and serine rich 1 | 2 | 2 | ||||||||
MIRT142614 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT143477 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT187759 | ESYT1 | extended synaptotagmin 1 | 2 | 2 | ||||||||
MIRT200250 | EVI5 | ecotropic viral integration site 5 | 2 | 2 | ||||||||
MIRT212867 | N4BP2 | NEDD4 binding protein 2 | 2 | 2 | ||||||||
MIRT219622 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 8 | ||||||||
MIRT220244 | FAM3C | family with sequence similarity 3 member C | 2 | 6 | ||||||||
MIRT222069 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT243478 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT261690 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT320184 | ITGB8 | integrin subunit beta 8 | 2 | 2 | ||||||||
MIRT441644 | CCNB1IP1 | cyclin B1 interacting protein 1 | 2 | 6 | ||||||||
MIRT441965 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 2 | ||||||||
MIRT442175 | TRIM59 | tripartite motif containing 59 | 2 | 4 | ||||||||
MIRT442716 | TNKS | tankyrase | 2 | 2 | ||||||||
MIRT443932 | ZNF418 | zinc finger protein 418 | 2 | 2 | ||||||||
MIRT445790 | ALG13 | ALG13, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT448148 | P2RY10 | purinergic receptor P2Y10 | 2 | 2 | ||||||||
MIRT463393 | ZDHHC20 | zinc finger DHHC-type containing 20 | 2 | 2 | ||||||||
MIRT463761 | YPEL2 | yippee like 2 | 2 | 2 | ||||||||
MIRT477233 | ETF1 | eukaryotic translation termination factor 1 | 2 | 2 | ||||||||
MIRT483464 | DR1 | down-regulator of transcription 1 | 2 | 6 | ||||||||
MIRT484110 | ABCD2 | ATP binding cassette subfamily D member 2 | 2 | 4 | ||||||||
MIRT487297 | SLC38A9 | solute carrier family 38 member 9 | 2 | 2 | ||||||||
MIRT501292 | RRN3 | RRN3 homolog, RNA polymerase I transcription factor | 2 | 4 | ||||||||
MIRT501343 | RNF44 | ring finger protein 44 | 2 | 4 | ||||||||
MIRT502696 | CSNK1G1 | casein kinase 1 gamma 1 | 2 | 4 | ||||||||
MIRT511075 | NIPA1 | non imprinted in Prader-Willi/Angelman syndrome 1 | 2 | 4 | ||||||||
MIRT511243 | KLHL36 | kelch like family member 36 | 2 | 6 | ||||||||
MIRT531418 | PLBD2 | phospholipase B domain containing 2 | 2 | 2 | ||||||||
MIRT536603 | IRF2 | interferon regulatory factor 2 | 2 | 2 | ||||||||
MIRT537727 | ELAVL2 | ELAV like RNA binding protein 2 | 2 | 2 | ||||||||
MIRT537985 | DPP8 | dipeptidyl peptidase 8 | 2 | 2 | ||||||||
MIRT539083 | ARNTL | aryl hydrocarbon receptor nuclear translocator like | 2 | 4 | ||||||||
MIRT547185 | PBRM1 | polybromo 1 | 2 | 2 | ||||||||
MIRT547596 | LIN28B | lin-28 homolog B | 2 | 2 | ||||||||
MIRT548188 | FOXA1 | forkhead box A1 | 2 | 2 | ||||||||
MIRT555055 | PYURF | PIGY upstream reading frame | 2 | 2 | ||||||||
MIRT557321 | HIC2 | HIC ZBTB transcriptional repressor 2 | 2 | 2 | ||||||||
MIRT557979 | FAM217B | family with sequence similarity 217 member B | 2 | 4 | ||||||||
MIRT558439 | DDIT4 | DNA damage inducible transcript 4 | 2 | 3 | ||||||||
MIRT558560 | CRLF3 | cytokine receptor like factor 3 | 2 | 4 | ||||||||
MIRT562332 | FGF2 | fibroblast growth factor 2 | 2 | 2 | ||||||||
MIRT565836 | SCML2 | Scm polycomb group protein like 2 | 2 | 2 | ||||||||
MIRT566796 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT568565 | AK4 | adenylate kinase 4 | 2 | 2 | ||||||||
MIRT572483 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT572586 | HGFAC | HGF activator | 2 | 2 | ||||||||
MIRT572876 | OPHN1 | oligophrenin 1 | 2 | 2 | ||||||||
MIRT573136 | ABT1 | activator of basal transcription 1 | 2 | 2 | ||||||||
MIRT573244 | ZBTB46 | zinc finger and BTB domain containing 46 | 2 | 2 | ||||||||
MIRT573388 | GGA2 | golgi associated, gamma adaptin ear containing, ARF binding protein 2 | 2 | 2 | ||||||||
MIRT574588 | N4BP1 | NEDD4 binding protein 1 | 2 | 2 | ||||||||
MIRT575081 | Ddit4 | DNA-damage-inducible transcript 4 | 2 | 3 | ||||||||
MIRT609077 | SMIM15 | small integral membrane protein 15 | 2 | 8 | ||||||||
MIRT619337 | RNF2 | ring finger protein 2 | 2 | 2 | ||||||||
MIRT623058 | NRXN1 | neurexin 1 | 2 | 2 | ||||||||
MIRT623307 | MARCH4 | membrane associated ring-CH-type finger 4 | 2 | 2 | ||||||||
MIRT623899 | FOXN3 | forkhead box N3 | 2 | 2 | ||||||||
MIRT625177 | GRIK4 | glutamate ionotropic receptor kainate type subunit 4 | 2 | 2 | ||||||||
MIRT630448 | GTPBP8 | GTP binding protein 8 (putative) | 2 | 2 | ||||||||
MIRT630587 | SLC9A8 | solute carrier family 9 member A8 | 2 | 2 | ||||||||
MIRT634451 | PAK6 | p21 (RAC1) activated kinase 6 | 2 | 2 | ||||||||
MIRT634727 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT635769 | PDCL3 | phosducin like 3 | 2 | 2 | ||||||||
MIRT650924 | ST6GALNAC1 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT668975 | CLSTN2 | calsyntenin 2 | 2 | 2 | ||||||||
MIRT669612 | AEBP2 | AE binding protein 2 | 2 | 2 | ||||||||
MIRT686746 | STX16 | syntaxin 16 | 2 | 2 | ||||||||
MIRT687932 | HMGN1 | high mobility group nucleosome binding domain 1 | 2 | 2 | ||||||||
MIRT691875 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT698432 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT698572 | TFDP2 | transcription factor Dp-2 | 2 | 2 | ||||||||
MIRT704500 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | 2 | 2 | ||||||||
MIRT704907 | CCDC71L | coiled-coil domain containing 71 like | 2 | 2 | ||||||||
MIRT713810 | XRCC2 | X-ray repair cross complementing 2 | 2 | 2 | ||||||||
MIRT718300 | MOGAT1 | monoacylglycerol O-acyltransferase 1 | 2 | 2 | ||||||||
MIRT719022 | SHROOM3 | shroom family member 3 | 2 | 2 | ||||||||
MIRT723766 | MPLKIP | M-phase specific PLK1 interacting protein | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|